Search Results (44)

More Search Options
MatchTypeWhy
A Catalog of 5' Fusion Partners in ROS1-Positive NSCLC Circa 2020.Academic Article Why?
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins.Academic Article Why?
Immunohistochemical Detection of ROS1 Fusion.Academic Article Why?
ROS1-rearranged Non-small Cell Lung Cancer.Academic Article Why?
Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient.Academic Article Why?
Ensartinib (X-396), an Approved ALK Inhibitor, Falls Out as a Clinically Relevant ROS1 Inhibitor.Academic Article Why?
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.Academic Article Why?
Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations.Academic Article Why?
Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis.Academic Article Why?
Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer.Academic Article Why?
CNS metastasis in ROS1+ NSCLC: An urgent call to action, to understand, and to overcome.Academic Article Why?
EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis.Academic Article Why?
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer.Academic Article Why?
Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers.Academic Article Why?
Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.Academic Article Why?
Per Page    Page  of 3 Next
Prev
With one click, see people who:

Mentor Faculty

Run Clinical Trials

Work in Global Health Equity

Offer Student Projects

See more options in the Advanced Search tab

Search Criteria
  • ROS1
Search Result Filters
_
Click "Why?" to see why an item matched the search.

UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

Copyright © The Regents of the University of California.